DNA Group (TR) (XTAE:DNA) Debt-to-Revenue : 0.00 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is DNA Group (TR) Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

DNA Group (TR)'s Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₪0.00 Mil. DNA Group (TR)'s Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₪0.00 Mil. DNA Group (TR)'s annualized Revenue for the quarter that ended in Dec. 2023 was ₪0.31 Mil. DNA Group (TR)'s annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.00.

DNA Group (TR) Debt-to-Revenue Historical Data

The historical data trend for DNA Group (TR)'s Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DNA Group (TR) Debt-to-Revenue Chart

DNA Group (TR) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

Get a 7-Day Free Trial

N/A

DNA Group (TR) Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial															N/A	N/A	-	-	-

Competitive Comparison of DNA Group (TR)'s Debt-to-Revenue

For the Biotechnology subindustry, DNA Group (TR)'s Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DNA Group (TR)'s Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DNA Group (TR)'s Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where DNA Group (TR)'s Debt-to-Revenue falls into.

DNA Group (TR) Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

DNA Group (TR)'s Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	0.306
	=	0.00

DNA Group (TR)'s annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	0.306
	=	0.00

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.

DNA Group (TR) Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of DNA Group (TR)'s Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.